BLACK DIAMOND THERAPEUTICS I (BDTX) Stock Balance Sheet
NASDAQ:BDTX - US09203E1055 - Common Stock
2.94 USD
+0.07 (+2.44%)
2.94 USD
0 (0%)
| MRQ (2025-6-30) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 29.99M | 36.44M | 56.22M | 34.30M | 65.80M | |||
| Marketable Securities | 112.84M | 62.14M | 75.18M | 88.50M | 144.00M | |||
| Other Current Assets | 3.90M | 2.60M | 2.63M | 4.90M | 5.90M | |||
| Total Current Assets | 146.73M | 101.18M | 134.03M | 127.70M | 215.70M | |||
| Non-Current Assets | ||||||||
| PPE Net | 18.67M | 20.40M | 23.71M | 27.40M | 30.70M | |||
| Other Non-Current Assets | 985.00K | 1.07M | 823.00K | 1.20M | 1.20M | |||
| Total Non-Current Assets | 19.66M | 21.46M | 24.53M | 28.60M | 32.00M | |||
| TOTAL ASSETS | 166.38M | 122.64M | 158.57M | 156.30M | 247.70M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Accrued Expenses | 16.03M | 16.57M | 17.32M | 13.40M | 19.50M | |||
| Accounts Payable | 771.00K | 4.01M | 2.32M | 1.90M | 4.10M | |||
| Other Current Liabilities | N/A | N/A | N/A | N/A | N/A | |||
| Total Current Liabilities | 16.80M | 20.57M | 19.65M | 15.30M | 23.60M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Other Non-Current Liabilities | 16.97M | 18.78M | 22.18M | 25.30M | 28.10M | |||
| Total Non-Current Liabilities | 16.97M | 18.78M | 22.18M | 25.30M | 28.20M | |||
| TOTAL LIABILITIES | 33.77M | 39.35M | 41.83M | 40.60M | 51.80M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -441.13M | -487.11M | -417.43M | -335.00M | -243.80M | |||
| Additional Paid In Capital | 573.75M | 570.36M | 534.19M | 452.50M | 440.10M | |||
| Common Shares | 7.00K | 7.00K | 7.00K | 0.00 | 0.00 | |||
| Other Shareholders' Equity | -25.00K | 24.00K | N/A | N/A | -400.00K | |||
| Shares Outstanding | 56.89M | 56.64M | 51.65M | 36.40M | 36.20M | |||
| Tangible Book Value per Share | 2.33 | 1.47 | 2.26 | 3.18 | 5.41 | |||
| Total Shareholders' Equity | 132.61M | 83.28M | 116.74M | 115.70M | 195.90M | |||
| TOTAL LIABILITIES AND EQUITY | 166.38M | 122.64M | 158.57M | 156.30M | 247.70M | |||
| Statistics | ||||||||
| Current Ratio | 8.73 | 4.92 | 6.82 | 8.35 | 9.14 | |||
| Return On Assets (ROA) | 8.68% | -56.81% | -51.99% | -58.33% | -50.71% | |||
| Return On Equity (ROE) | 10.89% | -83.66% | -70.62% | -78.80% | -64.11% | |||
| Return On Invested Capital (ROIC) | 2.48% | N/A | N/A | N/A | N/A | |||
| Return On Invested Capital Ex Cash (ROICexc) | 55.06% | N/A | N/A | N/A | N/A | |||
| Return On Invested Capital Ex Cash + Goodwill (ROICexcg) | 55.06% | N/A | N/A | N/A | N/A | |||
All data in USD , ROIC based on taxRate of 0.21